PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation

Gastroenterology

Volumn 134, Issue 1, 2008, Pages 166-178

  Dalmasso, Guillaume ^a   Charrier Hisamuddin, Laetitia ^a   Thu Nguyen, Hang Thi ^a   Yan, Yutao ^a   Sitaraman, Shanthi ^a   Merlin, Didier ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDE TRANSPORTER 1; TRIPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL STUDY; FEMALE; FLUID INTAKE; HISTOLOGY; IMMUNOCOMPETENT CELL; INTESTINE EPITHELIUM CELL; ISOTOPE LABELING; KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; T LYMPHOCYTE; WESTERN BLOTTING;

EID: 37349093017     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.10.026     Document Type: Article

References (33)

1. +/peptide cotransporter. Cloning, functional expression, and chromosomal localization. J Biol Chem 270 (1995) 6456-6463
2. Steel A., Nussberger S., Romero M.F., et al. Stoichiometry and pH dependence of the rabbit proton-dependent oligopeptide transporter PepT1. J Physiol 498 (1997) 563-569
3. Abidi S.A. The oligopeptide (PepT1) in human intestine: biology and function. Gastroenterology 113 (1997) 332-340
4. Abidi S.A. Regulation of expression of the intestinal oligopeptide transporter (PepT1) in health and disease. Am J Physiol 285 (2003) G779-G788
5. Daniel H. Molecular and integrative physiology of intestinal peptide transport. Annu Rev Physiol 66 (2004) 361-384
6. Daniel H., and Kottra G. The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pflugers Arch 447 (2004) 610-618
7. Fei Y.J., Ganapathy V., and Leibach F.H. Molecular and structural features of the proton coupled oligopeptide transporter superfamily. Prog Nucleic Acid Res Mol Biol 58 (1998) 239-261
8. Meredith D., and Boyd C.A.R. Structure and function of eukaryotic peptide transporter. Cell Mol Life Sci 57 (2000) 754-778
9. + peptide cotransport in the human bile duct epithelium cell line SK-ChA-1. Am J Physiol 283 (2002) G222-G229
10. +/peptide cotransporter in rat digestive tract. Biochem Biophy Res Commun 220 (1996) 848-852
11. +/peptide cotransporter mediating absorption of β-lactam antibiotics in the intestine and kidney. J Pharmacol Exp Ther 275 (1995) 1631-1637
12. Chen H., Smith D.E., Yang T., et al. Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney. Am J Physiol 276 (1999) F658-F665
13. Smith D.E., Pavlova A., Berger U.V., et al. Tubular localization and tissue distribution of peptide transporter in rat kidney. Pharmaceut Res 15 (1998) 1244-1249
14. +/di-tripeptide transporter (PepT1) expression in the rabbit intestine. Pflugers Arch 430 (1995) 394-400
15. Sai Y., Tamai I., Hayashi K., et al. Immunolocalization and pharmacological relevance of oligopeptide transporter PepT1 in intestinal absorption of beta-lactam antibiotics. FEBS Lett 392 (1996) 25-29
16. +/peptide transporter PepT1 in human intestine: up-regulated expression in the colonic mucosa of patients with short-bowel syndrome. Am J Clin Nutr 75 (2002) 922-930
17. Merlin D., Si-Tahar M., Sitaraman S.V., et al. Colonic epithelial hPepT1 expression occurs in inflammatory bowel disease: transport of bacterial peptides influence expression of MHC class 1 molecules. Gastroenterology 120 (2001) 1666-1679
18. Charrier L., Driss A., Yan Y., et al. hPepT1 mediates bacterial tripeptide fMLP uptake in human monocytes. Lab Invest 86 (2006) 490-503
19. Hiltz M.E., and Lipton J.M. Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide alpha-MSH. FASEB J 11 (1989) 2282-2284
20. Mandrika I., Muceniece R., and Wikberg J.E.S. Effects of melanocortin peptides on lipopolysaccharide/interferon-gamma-induced NF-kappaB DNA binding and nitric oxide production in macrophage-like RAW 264.7 cells: evidence for dual mechanisms of action. Biochem Pharmacol 61 (2001) 613-621
21. Kelly J.M., Moir A.J., Carlson K., et al. Immobilized α-melanocyte stimulating hormone 10-13 (GKPV) inhibits tumor necrosis factor-α stimulated NF-κB activity. Peptide 27 (2006) 431-437
22. Cooper A., Robinson S.J., Pickard C., et al. α-melanocyte-stimulating hormone suppresses antigen-induced lymphocyte proliferation in humans independently of melanocortin 1 receptor gene status. J Immunol 175 (2005) 4806-4813
23. Jobin C., Haskill S., Mayer L., et al. Evidence for altered regulation of IκBα degradation in human colonic epithelial cells. J Immunol 158 (1997) 226-234
24. Hoffmann E., Dittrich-Breiholz O., Holtmann H., et al. Multiple control of interleukin-8 gene expression. J Leukoc Biol 72 (2002) 847-855
25. McCormick B.A., Colgan S.P., Delp-Archer C., et al. Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils. J Cell Biol 123 (1993) 895-907
26. 193-195 receptor antagonism in the alveolar epithelium. Biochem J 355 (2001) 29-38
27. Strober W., Fuss I.J., and Blumberg R.S. The immunology of mucosal models of inflammation. Annu Rev Immunol 20 (2002) 495-549
28. Rajora N., Boccoli G., Catania A., et al. α-MSH modulates experimental inflammatory bowel disease. Peptides 18 (1997) 381-385
29. Oktar B.K., Ercan F., Yeǧen B.C., et al. The effect of α-melanocyte stimulating hormone on colonic inflammation in the rat. Peptides 21 (2000) 1271-1277
30. Getting S.J. Targeting melanocortin receptors as potential novel therapeutics. Pharmacol Ther 111 (2006) 1-15
31. Getting S.J., Schiöth H.B., and Perretti M. Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) α-melanocyte-stimulating hormone peptides. J Pharmacol Exp Ther 306 (2003) 631-637
32. Schiöth H.B., Muceniece R., Mutule I., et al. New melanocortin 1 receptor binding motif based on the C-terminal sequence of α-melanocyte-stimulating hormone. Basic Clin Toxicol Pharmacol 99 (2006) 287-293
33. + cotransport system in the Caco-2 human colon carcinoma cell line. Biochem J 299 (1994) 253-260